- Home
- BDRX vs KXIN Comparison
BDRX vs KXIN Comparison
Compare BDRX & KXIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BDRX
- KXIN
- Stock Information
- Founded
- BDRX 2000
- KXIN 2015
- Country
- BDRX United Kingdom
- KXIN China
- Employees
- BDRX N/A
- KXIN N/A
- Industry
- BDRX Biotechnology: Pharmaceutical Preparations
- KXIN Retail-Auto Dealers and Gas Stations
- Sector
- BDRX Health Care
- KXIN Consumer Discretionary
- Exchange
- BDRX Nasdaq
- KXIN Nasdaq
- Market Cap
- BDRX 5.8M
- KXIN 13.0M
- IPO Year
- BDRX N/A
- KXIN N/A
- Fundamental
- Price
- BDRX $0.86
- KXIN $0.93
- Analyst Decision
- BDRX
- KXIN
- Analyst Count
- BDRX 0
- KXIN 0
- Target Price
- BDRX N/A
- KXIN N/A
- AVG Volume (30 Days)
- BDRX 3.1M
- KXIN 83.1K
- Earning Date
- BDRX 04-11-2025
- KXIN 01-01-0001
- Dividend Yield
- BDRX N/A
- KXIN N/A
- EPS Growth
- BDRX N/A
- KXIN N/A
- EPS
- BDRX N/A
- KXIN N/A
- Revenue
- BDRX N/A
- KXIN N/A
- Revenue This Year
- BDRX N/A
- KXIN N/A
- Revenue Next Year
- BDRX N/A
- KXIN N/A
- P/E Ratio
- BDRX N/A
- KXIN N/A
- Revenue Growth
- BDRX N/A
- KXIN N/A
- 52 Week Low
- BDRX $0.78
- KXIN $0.64
- 52 Week High
- BDRX $41.50
- KXIN $29.54
- Technical
- Relative Strength Index (RSI)
- BDRX 36.41
- KXIN 51.70
- Support Level
- BDRX $0.83
- KXIN $0.90
- Resistance Level
- BDRX $0.90
- KXIN $1.10
- Average True Range (ATR)
- BDRX 0.11
- KXIN 0.06
- MACD
- BDRX 0.00
- KXIN 0.01
- Stochastic Oscillator
- BDRX 14.57
- KXIN 43.40
About BDRX Biodexa Pharmaceuticals plc
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.
About KXIN Kaixin Auto Holdings
Kaixin Holdings is an auto retail platform for luxury used cars and imported new cars. The company is actively engaged in the research and development, design, manufacturing, and sales of electric vehicles and promotes the innovation of next-generation autonomous driving and artificial intelligence technologies. The company generates revenues from sales of used cars, as well as fees obtained from its role as a channel partner for third-party auto financing and other value-added service providers.